SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY

Clinical trials for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY trials appear

Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

Doctors test custom vaccine to fight returning head and neck cancer

Disease control Recruiting now

This early-stage study is testing a personalized vaccine made from a patient's own tumor cells. It aims to see if the vaccine, given alone or with an immunotherapy drug (pembrolizumab), is safe and can help the immune system fight advanced head and neck cancer that has returned o…

Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY

Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY

Get alerted when new SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY trials appear

Doctors test custom vaccine to fight returning head and neck cancer